Table 1.

Summary of timed data (weeks) regarding onset, mid-point, and endstage of the disease in the SOD1(G93A)-tg mice treated s.c. with G-CSF

	Vehicle	G-CSF	Difference (%)
Time to clinical onset
Clinical	17.0	18.8	10.8
Rotarod	15.4	19.2	25.2
Grip Strength	15.0	18.1	20.4
Time to 50% impairment
Rotarod	18.4	21.6	17.8
Grip strength	17.4	20.1	15.2
Time to endstage
Clinical	21.7	23.2	7.0
Rotarod	20.8	22.8	10.0
Grip strength	19.5	21.7	11.2

All differences are significant (logrank; p<0.05).